Web-based surveys are a feasible way of rapidly collecting drug safety data on novel vaccines when they are rolled out quickly over a large area, according to a new European study involving the UK’s leading drug safety unit.
The study, conducted in seven European countries, aimed to prospectively monitor the safety of the COVID-19 vaccines as they were rolled out at scale.
